Titan Company Net Profit Rises 48% To Rs 529 Crore In March Quarter
Tata group-owned Titan Company reported a 48 per cent growth in net profit to Rs 529 crore on a standalone basis, in the January-March quarter of the financial year 2020-21, compared to Rs 357 crore in the corresponding period last year. According to a regulatory filing by the company to the BSE on Thursday, April 29, Titan Company's revenue from operations stood at Rs 7,135 crore in the March quarter, marking a 61 per cent growth, compared to Rs 4,429 crore in the same period last year. (Also Read: Titan Falls Over 2% After Net Profit Drops 11% In December Quarter )
According to the statement, the company's board recommended a dividend of Rs 4 per equity share of rupee one each of the company, that will be dispatched or paid subject to the approval of the shareholders of the firm.
Titan stated that the company reported a strong revenue growth both in the jewellery and the eyewear segments, while the watches division recovered in the fourth quarter of the financial year 2020-21. The total income stood at Rs 7,169 crore in the March quarter, compared to Rs 4,469 crore in the corresponding quarter last year.
The jewellery segment registered an income of Rs. 6,397 crore in the March quarter, excluding gold bullion sales, compared to Rs. 3,754 crore in the year-ago period. The watches and wearables business recovered in the fourth quarter to register an income of Rs. 555 crore, compared to Rs. 557 crores in the same period last year.
On Thursday, shares of Titan Company settled 0.13 per cent lower at Rs 1,506.30 apiece on the BSE. Titan opened on the BSE at Rs 1,519.80, registering an intra day high of Rs 1,527.35 and an intra day low of Rs 1,497.10 through the trading session. On the NSE, Titan Company settled 0.30 per cent lower at Rs 1,504.35 apiece.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.